Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AbbVie, Amgen, Merck - Research and Markets
On Thursday, Human Genome Sciences HGSI announced full positive Phase IIb Albuferon trial results from a study done on genotype 1 hepatitis C patients. We are maintaining our fair value estimate as we had already assigned a success rate for Albuferon equivalent to a Phase III drug when interim data ...
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
Equity valuations as a whole have barely budged in 2005, but the market remains a bit on the pricey side when comparing to Morningstar's collective fair value estimates (To see more on Morningstar's perspective on market valuations, check out our Market Valuation Graph ). The median stock in our ...
We look at how a biotech ETF holds up in an iffy climate for those stocks.
Human Genome Sciences' two big drugs could make up for years of losses.